Earnings History Data for Phio Pharmaceuticals Corp. (PHIO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is focused on developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi therapeutic platform. The Company's pipeline consists of RXI-762 and RXI-804 which are in clinical stage. Phio Pharmaceuticals Corp, formerly known as RXi Pharmaceuticals Corporation, is based in Marlborough, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | PM | PHIO | Phio Pharmaceuticals Corp. | 2.20 | -1.54 | 0.00 | -10.26 | Phio Pharmaceuticals GAAP EPS of -$1.54 beats by $2.60 [11/15/2024 2:48 AM] |
2.19 | -0.04 (-1.78%) |
2.50 | 0.27 (12.11%) |
2.17 - 18.81 | 49,496 | 40,000 | 1,163 | ||
| 09-05-2024 | PM | PHIO | Phio Pharmaceuticals Corp. | 3.84 | -0.47 | 0.00 | -3.15 | Phio Pharmaceuticals GAAP EPS of -$0.47 [5/10/2024 1:57 AM] |
0.7004 | -0.07 (-9.04%) |
0.75 | -0.02 (-2.60%) |
0.50 - 6.85 | 48,020 | 160,000 | 3,543 | ||
| 22-03-2022 | AH | PHIO | Phio Pharmaceuticals | 11.00 | -0.25 | -0.32 | 0.00 | Phio Pharmaceuticals GAAP EPS of -$1.04 beats by $0.07 [3/22/2022 5:28 PM] |
0.9302 | 0.03 (3.33%) |
0.8999 | 0.0 (-0.03%) |
0.70 - 3.02 | 862,318 | 250,000 | 23,156 | ||
| 10-11-2021 | AH | PHIO | Phio Pharmaceuticals Corp. | 23.28 | -0.28 | -0.25 | -0.40 | Phio Pharmaceuticals EPS misses by $0.03 [11/10/2021 5:10 PM] |
1.58 | -0.05 (-3.07%) |
1.61 | -0.02 (-1.23%) |
1.53 - 4.36 | 300,149 | 140,000 | 9,372 | ||
| 12-08-2021 | AH | PHIO | Phio Pharmaceuticals Corp. | 25.72 | -0.20 | -0.26 | -0.34 | Phio Pharmaceuticals EPS beats by $0.06 [8/12/2021 5:06 PM] |
1.71 | -0.04 (-2.29%) |
1.80 | 0.05 (2.86%) |
1.70 - 4.36 | 380,761 | 440,000 | 3,695 | ||
| 25-03-2021 | AH | PHIO | Phio Pharmaceuticals Corp. | 36.36 | -0.41 | -0.42 | -4.69 | Phio Pharmaceuticals EPS in-line [3/25/2021 5:19 PM] |
2.79 | 0.05 (1.82%) |
2.92 | 0.18 (6.57%) |
1.60 - 6.48 | 426,495 | 580,000 | 4,774 | ||
| 10-11-2020 | AH | PHIO | Phio Pharmaceuticals Corp. | 12.89 | -0.40 | -0.38 | -4.40 | Phio Pharmaceuticals EPS misses by $0.02 [11/10/2020 5:07 PM] |
2.35 | -0.14 (-5.44%) |
2.31 | -0.17 (-6.85%) |
1.60 - 18.15 | 370,119 | 1,245,059 | 21,083 | ||
|
|
||||||||||||||||||